Advent International L.P. acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 25,450 shares of the semiconductor company’s stock, valued at approximately $12,557,000. Synopsys makes up about 0.3% of Advent International L.P.’s holdings, making the stock its 22nd largest position.
A number of other hedge funds also recently added to or reduced their stakes in SNPS. Vanguard Group Inc. lifted its position in shares of Synopsys by 20.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock valued at $8,970,415,000 after acquiring an additional 3,120,401 shares during the period. State Street Corp grew its holdings in shares of Synopsys by 1.2% in the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after acquiring an additional 85,662 shares during the period. Victory Capital Management Inc. increased its stake in Synopsys by 238.8% in the 3rd quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock valued at $1,393,506,000 after purchasing an additional 1,990,608 shares in the last quarter. Ameriprise Financial Inc. increased its stake in Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after purchasing an additional 585,494 shares in the last quarter. Finally, Capital Research Global Investors raised its holdings in Synopsys by 226.6% during the third quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock worth $1,245,533,000 after purchasing an additional 1,751,432 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Stock Performance
Synopsys stock opened at $412.63 on Friday. The stock’s 50-day moving average is $461.93 and its 200-day moving average is $463.65. The company has a market cap of $79.04 billion, a price-to-earnings ratio of 64.07, a price-to-earnings-growth ratio of 3.36 and a beta of 1.15. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.
Insider Buying and Selling
In other news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 4,157 shares of company stock worth $1,945,036. 0.56% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of analysts have commented on the company. HSBC downgraded Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price on the stock. in a research report on Friday, February 20th. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and dropped their price target for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Needham & Company LLC reiterated a “buy” rating on shares of Synopsys in a research report on Thursday, February 26th. JPMorgan Chase & Co. increased their price objective on shares of Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Synopsys currently has an average rating of “Hold” and an average target price of $531.00.
Check Out Our Latest Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
